Primary Site >> Biliary tract Cancer
Gene >> CEACAM3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Diagnostic values of serum CEA in patients with cancer of gallbladder (author's transl)]. PMID: 541532 |
Ref: Ampullary carcinoma associated with multiple duodenal villous adenomas. PMID: 6158264 Ref: CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure. PMID: 7461595 |
Ref: Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Correlation with cytology and percutaneous transhepatic cholangiography. PMID: 7139579 |
Ref: [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors]. PMID: 6095018 Ref: Immunohistochemistry of carcinoembryonic antigen, secretory component and lysozyme in benign and malignant common bile duct tissues. PMID: 6428041 Ref: [Ultrasonically guided biopsy of mass lesions in the pancreas, liver and gallbladder]. PMID: 6732258 |
Ref: Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. PMID: 2412682 Ref: [Serum levels and clinical evaluation of CA 19-9 in various diseases]. PMID: 2582158 Ref: Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. PMID: 2986349 Ref: Diagnosis of duodenal and ampullary epithelial neoplasms by endoscopic biopsy: a clinicopathologic and immunohistochemical study. PMID: 4029945 |
Ref: Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias. PMID: 3004013 Ref: Detection of specific anti-antibodies in patients treated with radiolabeled antibody. PMID: 3013817 Ref: Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. PMID: 3457770 Ref: [Study on the clinical application of plasma and tissue carcinoembryonic antigen to cases with bile duct carcinoma]. PMID: 3713684 |
Ref: [A case of intrahepatic cholangiocarcinoma with marked high levels of CEA, AFP and CA 19-9]. PMID: 2437230 Ref: Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. PMID: 2441731 |
Ref: Undifferentiated carcinoma of the gallbladder. A clinicopathologic, histochemical, and immunohistochemical study of 21 patients with a poor prognosis. PMID: 2451557 Ref: [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers]. PMID: 2456040 Ref: Cancer of the extrahepatic bile duct: a clinicopathologic study of immunohistochemistry for CEA, CA19-9, and p21. PMID: 2830725 Ref: Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis. PMID: 3048082 Ref: Immunohistochemistry of human gastrointestinal cancer-associated antigen detected by monoclonal antibody PA 8-15. PMID: 3130361 Ref: [Successful treatment with tegafur and PSK in a patient with gallbladder cancer]. PMID: 3137892 |
Ref: A case of gallbladder carcinoma producing both alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA). PMID: 2472996 Ref: Duct-islet cell tumor of the pancreas. A case report with immunohistochemical and electron microscopic findings. PMID: 2558493 Ref: [Immunohistochemical study of cancer-associated carbohydrate antigens in carcinoma of the biliary tract]. PMID: 2560529 Ref: [Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers]. PMID: 2571740 Ref: [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer]. PMID: 2730018 Ref: Carcinoid tumors of the gallbladder with adenocarcinomatous differentiation: a morphologic and immunohistochemical study. PMID: 2756987 Ref: Pathophysiology of tumor progression in human gallbladder: flow cytometry, CEA, and CA 19-9 levels in bile and serum in different stages of gallbladder disease. PMID: 2795683 Ref: [Histogenesis of gallbladder cancer with special reference to metaplastic changes and distribution of various mucins and CEA]. PMID: 2796960 |
Ref: Evaluation of non-invasive diagnostic tests in detecting cancer of the pancreas. PMID: 2125254 Ref: [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer]. PMID: 2212836 Ref: Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? PMID: 2335386 Ref: Detection of tumor associated antigen, PA8-15, in sera from pancreatic and gastrointestinal carcinoma patients. PMID: 2370693 |
Ref: Variable low dose rate irradiation (131I-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma. PMID: 1657845 Ref: [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]. PMID: 1709347 Ref: Tumour marker CA 125 in patients with digestive tract malignancies. PMID: 1715601 Ref: [A diffuse metastatic leptomeningeal carcinomatosis from gallbladder cancer; case report]. PMID: 1762661 Ref: [Immunohistochemical expression of the carcinoembryonic antigen in gallbladder cancer]. PMID: 1824154 Ref: Immunohistochemistry in the differential diagnosis of liver carcinomas. PMID: 1847609 Ref: [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer]. PMID: 1886576 Ref: Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. PMID: 2021550 Ref: Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9. PMID: 2072697 |
Ref: Surgical treatment of periampullary cancer--review of 766 surgical experiences of 8 hospitals. PMID: 1299231 Ref: [Heterogeneous carcinoma of the gallbladder with neuroendocrine differentiation]. PMID: 1321005 Ref: [Gallbladder cancer: immunohistochemical expression of CA-19-9, epithelial membrane antigen, dupan-2 and carcinoembryonic antigen]. PMID: 1340939 |
Ref: Adenoendocrine cell carcinoma of the gallbladder: a histochemical and immunohistochemical study. PMID: 7686712 Ref: Carcinoma of the ampulla of Vater. PMID: 7906119 Ref: Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis. PMID: 8358193 Ref: The evaluation of tumor markers levels in determination of surgical procedure in patients with gallbladder carcinoma. PMID: 8569609 |
Ref: Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma. PMID: 8146530 Ref: Carcinoembryonic antigen (CEA) and CEA-related substances in the bile of patients with biliary diseases. PMID: 8160902 Ref: [A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy]. PMID: 8185350 Ref: Incidence and pathogenesis of villous tumors of the gallbladder, and their relation to cancer. PMID: 8199698 |
Ref: Hepatolithiasis associated with cholangiocarcinoma. PMID: 7676713 Ref: Clear cell carcinomas of the gallbladder and extrahepatic bile ducts. PMID: 7802141 Ref: Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. PMID: 7875490 Ref: Intrahepatic sarcomatous cholangiocarcinoma. PMID: 8574344 Ref: Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas. PMID: 8751192 |
Ref: Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. PMID: 8554130 Ref: Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis. PMID: 8591850 Ref: [Gallbladder carcinoma producing CEA, AFP, CA19-9, sialyl SSEA and CSF]. PMID: 8705462 Ref: Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. PMID: 8859179 Ref: Alpha-fetoprotein, carcinoembryonic antigen, and carbohydrate antigen 19-9-producing gallbladder cancer. PMID: 8887046 |
Ref: [A case of recurrent gallbladder cancer with marked response to arterial infusion chemotherapy and transarterial embolization]. PMID: 9020952 Ref: Surgical treatment of cholangiocarcinoma. PMID: 9222685 Ref: Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA. PMID: 9310245 |
Ref: Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level. PMID: 9658330 Ref: Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. PMID: 9717998 |
Ref: An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19. PMID: 10365850 Ref: Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancer. PMID: 10414697 Ref: Prevention of bile duct cancer in primary sclerosing cholangitis. PMID: 10436824 Ref: Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. PMID: 10642939 Ref: High serum concentrations of sialyl Tn antigen in carcinomas of the biliary tract and pancreas. PMID: 10664288 |
Ref: CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. PMID: 10601548 Ref: Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. PMID: 10873083 Ref: Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies. PMID: 11326643 |
Ref: Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. PMID: 11420469 Ref: Measurement of circulating biliary glycoprotein (CD66a) in liver diseases. PMID: 11480791 Ref: Value of serum CEA and AFP in the diagnosis and prognosis of carcinoma gallbladder. PMID: 11963335 |
Ref: The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis. PMID: 12063953 Ref: Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. PMID: 12063982 Ref: Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. PMID: 12430077 Ref: Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment. PMID: 12473192 |
Ref: Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis. PMID: 12629979 Ref: [Cholangiocarcinoma--bile ducts cancer]. PMID: 12901270 Ref: Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. PMID: 12971966 Ref: Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. PMID: 14571813 Ref: The role of bile carcinoembryonic antigen in diagnosing bile duct cancer. PMID: 14676443 |
Ref: Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. PMID: 14760772 Ref: Establishment and characterization of unique human gallbladder cancer cell lines. PMID: 15067341 Ref: [Biomarkers for neoplasmas in digestive organs]. PMID: 15272578 Ref: A comparative clinical study of gallbladder tubular adenocarcinoma according to the grade of differentiation. PMID: 15549451 Ref: [Detection of bone marrow micrometastases in patients with gallbladder cancer]. PMID: 15743160 |
Ref: Cytokeratin is a superior marker for detection of micrometastatic biliary tract carcinoma. PMID: 15836844 Ref: Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report. PMID: 16049296 |
Ref: The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. PMID: 16680226 Ref: Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. PMID: 16941699 Ref: Hepatectomy for peripheral cholangiocarcinoma in elderly patients. PMID: 17009157 Ref: Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. PMID: 17072981 |
Ref: Carcinosarcoma of the liver with mesenchymal differentiation. PMID: 17278210 Ref: Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies. PMID: 17424828 Ref: Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. PMID: 17431781 Ref: Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy. PMID: 18265660 |
Ref: Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. PMID: 17955299 Ref: Primary sclerosing cholangitis: detection of cancer in strictures. PMID: 17999125 Ref: Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. PMID: 18057991 Ref: Lymphoepithelioma-like cholangiocarcinoma not associated with EBV. PMID: 18067645 Ref: Renal cell carcinoma with unusual metastasis to the gallbladder. PMID: 18392717 Ref: Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. PMID: 18425077 Ref: Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine. PMID: 18987939 Ref: Intrahepatic cholangiocarcinoma arising in chronic viral hepatitis-associated cirrhosis: two transplant cases. PMID: 19100500 |
Ref: Endocrine cells in ampullary carcinoma. PMID: 19214369 Ref: Adenoendocrine cell carcinoma of the gallbladder clinically mimicking squamous cell carcinoma. PMID: 19390950 Ref: [Prognosis of 84 intrahepatic cholangiocarcinoma patients]. PMID: 19624884 Ref: [Two cases of inoperable advanced bileduct cancer treated effectively with a gemcitabine/cisplatin combination]. PMID: 19920395 Ref: [Analysis of prognostic factors influencing the outcome of intrahepatic cholangiocarcinoma]. PMID: 20137350 |
Ref: [Detection of lymph node micrometastasis for patients with extrahepatic cholangiocarcinoma and its prognostic significance]. PMID: 20450726 Ref: Primary mixed lymphoepithelioma-like carcinoma and intra-hepatic cholangiocarcinoma: a case report and review of literature. PMID: 20830246 Ref: p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis. PMID: 20935395 Ref: Tumor markers as a diagnostic key for hilar cholangiocarcinoma. PMID: 20947473 Ref: Cytoplasmic overexpression with membrane accentuation of stratifin in intrahepatic mass-forming cholangiocarcinoma after hepatectomy: correlation with clinicopathologic features and patient survival. PMID: 20976731 |
Ref: [Examination of the patient serum presenting a CEA false high value after cancer immuno-cell therapy]. PMID: 21942086 |
Ref: Evaluation of CA 242 as a tumor marker in gallbladder cancer. PMID: 21573879 Ref: Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer. PMID: 21882202 Ref: Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. PMID: 22246855 Ref: Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? PMID: 22504729 Ref: Diagnosis and cure experience of hepatolithiasis-associated intrahepatic cholangiocarcinoma in 66 patients. PMID: 22524851 Ref: Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis. PMID: 22580675 Ref: S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas. PMID: 22882148 Ref: Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry. PMID: 22888427 Ref: Role of radical surgery in patients with stage IV gallbladder cancer. PMID: 23134181 Ref: Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report. PMID: 23226802 Ref: Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer. PMID: 26388908 Ref: Clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct. PMID: 26388924 |
Ref: Undifferentiated spindle-cell carcinoma of the gallbladder: a report of a case, an immunohistochemistry profile, and a review of the literature. PMID: 23476861 Ref: A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. PMID: 23506840 Ref: Incidence of primary colorectal cancer from colonoscopy examinations in patients presenting with liver mass. PMID: 23682528 Ref: Tumor biomarkers: help or mislead in the diagnosis of xanthogranulomatous cholecystitis?-analysis of serum CA 19-9, carcinoembryonic antigen, and CA 12-5. PMID: 23981609 Ref: [Expression of pGSK-3alpha/beta Tyr279/216 and XIAP proteins in cholangiocarcinoma and their clinical significance]. PMID: 24054014 |
Ref: Primary squamous cell carcinoma of the ampulla of Vater. PMID: 24413783 Ref: Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. PMID: 24744600 Ref: Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer. PMID: 24900151 Ref: Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19-9 and carcinoembryonic antigen. PMID: 24931246 Ref: Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions. PMID: 25003676 Ref: Surgical management of biliary cystadenoma and cystadenocarcinoma of the liver. PMID: 25158256 Ref: [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma]. PMID: 25341348 Ref: Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study. PMID: 25368272 Ref: [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma]. PMID: 25564055 Ref: [A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy]. PMID: 25731241 Ref: [Long-term survivor of unresectable bile duct cancer complicated with sclerosing cholangitis treated with chemotherapy]. PMID: 25731246 |
Ref: Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. PMID: 24509187 Ref: Nimesulide-induced fatal acute liver failure in an elderly woman with metastatic biliary adenocarcinoma. A case report. PMID: 25250798 Ref: Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma. PMID: 25921161 Ref: Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. PMID: 26060332 Ref: Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. PMID: 26074706 Ref: Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. PMID: 26077119 Ref: Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. PMID: 26206643 Ref: Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer. PMID: 26401081 |
Ref: A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. PMID: 26683498 Ref: A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis. PMID: 26966527 Ref: Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. PMID: 26974756 Ref: Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers. PMID: 27079357 Ref: Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer. PMID: 27142076 Ref: Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers. PMID: 27223281 Ref: [Analysis of the survival of 123 patients with intrahepatic cholangiocarcinoma after surgical resection]. PMID: 27346406 Ref: Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States. PMID: 28078124 Ref: [Surgical Resection after Gemcitabine plus Cisplatin Chemotherapy for Intrahepatic Cholangiocarcinoma with Multiple Lymph Node Metastases - Report of a Case]. PMID: 28133124 |
Ref: Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study. PMID: 27358229 Ref: Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma. PMID: 27806633 Ref: Clinical Performance of CEA, CA19-9, CA15-3, CA125 and AFP in Gastrointestinal Cancer Using LOCI-based Assays. PMID: 28011514 Ref: Sarcomatoid carcinoma of the common bile duct: A case report. PMID: 28099333 Ref: CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy. PMID: 28111425 Ref: Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. PMID: 28169208 Ref: Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study. PMID: 28373474 Ref: Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. PMID: 28375170 Ref: Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma. PMID: 28750922 Ref: Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer. PMID: 28875420 Ref: Histopathological study of gallbladder carcinoma and its mimics with role of carcinoembryonic antigen immunomarker in resolving diagnostic difficulties. PMID: 29333003 Ref: [Long-Term Survival in a Patient with Combined Hepatocellular-Cholangiocarcinoma Treated with Multidisciplinary Therapy - A Case Report]. PMID: 29394535 Ref: [A Case of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern]. PMID: 29394806 |
Ref: Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis. PMID: 28838033 Ref: Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy. PMID: 29069888 Ref: Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma. PMID: 29374731 Ref: The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma. PMID: 29438681 Ref: Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review. PMID: 29637880 Ref: A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass. PMID: 29720881 Ref: Long-term outcomes and prognostic markers in gallbladder cancer. PMID: 29995783 Ref: Rare case of a gallbladder neuroendocrine carcinoma. PMID: 30003469 Ref: Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at (18)F-FDG-PET/CT: prognostic implication of metabolic parameters and tumor markers. PMID: 30022384 Ref: The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma. PMID: 30191731 Ref: Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma. PMID: 30210635 Ref: Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report. PMID: 30219954 |